Birmingham, West Midlands -- (SBWIRE) -- 12/24/2013 -- Value Penny Stocks issues special report on - Mechel OAO (ADR) (NYSE:MTL), Goodrich Petroleum Corporation (NYSE:GDP), Myriad Genetics, Inc (NASDAQ:MYGN)
Mechel OAO (ADR) (NYSE:MTL) opened the session at $2.45 and closed the session at $2.52. The stock showed a positive performance of 3.28% in previous trading session. Traded with volume of 1.66 million shares in the prior session and the average volume of the stock remained 2.39 million shares. Mechel OAO is a Russia-based integrated mining and steel company. The Company focuses on the production of mining products, such as coal, iron ore, nickel, and steel products. Its operations are divided into two segments: Mining and Steel. The Mining segment focuses on the production and sales of coking coal concentrate, iron ore concentrate and coke with assets in the Russian Federation and the United States. The Steel segment comprises production and sale of semi-finished steel products, carbon and specialty long products, stainless flat products, and value-added downstream metal products,
For How Long MTL will fight for Profitability? Read This Trend Analysis report
Goodrich Petroleum Corporation (NYSE:GDP) opened the session at $18.04 and closed the session at $17.23. The stock showed a negative performance of -3.31% in previous trading session. The beta of the stock remained 1.78. Goodrich Petroleum Corporation is an independent oil and natural gas company engaged in exploration, development and production of oil and natural gas on properties primarily in Northwest Louisiana, East Texas and South Texas. It includes the Haynesville Shale and Cotton Valley Taylor Sand in Northwest Louisiana and East Texas, the Eagle Ford Shale and Buda Lime formations in South Texas and the Tuscaloosa Marine Shale in Southeast Louisiana and Southwest Mississippi. It owns interests in 401 producing oil and natural gas wells.
Why Should Investors Buy GDP After the Recent Fall? Just Go Here and Find Out
Myriad Genetics, Inc (NASDAQ:MYGN) the stock decreased -0.58% and finished the session at $23.86. Traded with volume of 1.63 million shares in the prior session and the average volume of the stock remained 2.41 million shares. The beta of the stock remained 0.47. Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis.
Will MYGN Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)